Tariquidar

Tariquidar
Clinical data
ATC code
  • none
Identifiers
IUPAC name
  • N-[2-[[4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC38H38N4O6
Molar mass646.744 g·mol−1
3D model (JSmol)
SMILES
  • COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC
InChI
  • InChI=1S/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43) ☒N
  • Key:LGGHDPFKSSRQNS-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Tariquidar (INN/USAN) is a potent P-glycoprotein inhibitor and a substrate of breast cancer protein (BCRP/ABCG2)[1] undergoing research as an adjuvant against multi-drug resistance in cancer.

References

  1. ↑ Weidner, Lora D; Fung, King Leung; Kannan, Pavitra; Moen, Janna K; Kumar, Jeyan S; Mulder, Jan; Innis, Robert B; Gottesman, Michael M; Hall, Matthew D (February 2016). "Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein". Drug Metabolism and Disposition. 44 (2): 275–282. doi:10.1124/dmd.115.067785. PMC 4746486. PMID 26658428.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.